Skip to main content
SpringerLink
Log in

Implantable Cardioverter Defibrillator: A Therapy for Everyone or for Selected Patients?

  • Conference paper
Cardiac Arrhythmias 1995

  • 104 Accesses

Abstract

The implantable cardioverter defibrillator (ICD) is an important and unique new method of potentially preventing recurrent sudden cardiac death (SCD) due to malignant ventricular arrhythmias (MVA).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Kappenberger LJ (1995) Reflections on guidelines for the use of ICD. In: Camm J and Lindeman F (eds) Transvenous defibrillation and radiofrequency ablation. Futura, New York, pp 65–71

    Google Scholar 

  2. ACC/AHA Task Force Report (1991) Guidelines for implantation of cardiac pace-makers and antiarrhythmic devices. J Am Coll Cardiol 18: 1–8

    Google Scholar 

  3. Lehmann MH, Saksena S (1991) ICD in cardiovascular practice. Report of the policy conference of the Naspe. PACE 14: 969–979

    Google Scholar 

  4. Brugada P, Andries E (1991) The patient with malignant ventricular tachyarrhythmias can be offered optimal treatment on the basis of simple clinical variables. PACE 14: 1201–1204

    Article  PubMed  CAS  Google Scholar 

  5. Fogoros RN, Elson J et al (1990) Efficacy of AICD in prolonging survival in patients with severe heart failure. J Am Coll Cardiol 16: 381–386

    Article  PubMed  CAS  Google Scholar 

  6. Hentmorn RW (1991) Are the benefits of AICD overstimated by SCD rate? J Am Coll Cardiol 7: 1593–1595

    Article  Google Scholar 

  7. Kocks M, Eggeling T et al (1993) Pharmacological therapy in coronary artery disease. Eur Heart J 14: 107–112

    Google Scholar 

  8. Task Force of the European Society of Cardiology (1992) Guidelines for the use of ICD. Eur Heart J 13: 1304–1310

    Google Scholar 

  9. Winkle RA, Mead RH et al (1989) Long-term outcome with the AICD. J Am Coll Cardiol 13: 1353–1361

    Article  PubMed  CAS  Google Scholar 

  10. Furman S (1989) AICD benefit. PACE 12: 399–400

    CAS  Google Scholar 

  11. Connolly S, Yusuf S (1992) Evaluation of ICD in survivors of cardiac arrest: the need for randomized trials. Am J Cardiol 89: 959–962

    Article  Google Scholar 

  12. Kim SG (1993) ICD therapy. Am J Cardiol 71: 1212–1218

    Google Scholar 

  13. Doval H, Nul D et al (1994) Randomized trial of low dose Amiodarone in severe congestive heart failure. Lancet 344: 493–499

    Article  PubMed  CAS  Google Scholar 

  14. Teo K, Yusuf S et al (1993) Effect of prophylactic antiarrhythmic drug therapy in myocardial infarction. JAMA 270: 15981596

    Google Scholar 

  15. Mason JW (1993) A comparison of 7 antiarrhythmic drugs in patients with ventricular tachyarrhythmias. N Engl J Med 329: 452–457

    Article  PubMed  CAS  Google Scholar 

  16. Steinbeck G, Andresen D et al (1992) A comparison of EPSguided antiarrhythmic drug therapy in patients with symptomatic sustained ventricular tachyarrhythmias. N Engl J Med 367: 987–993

    Article  Google Scholar 

  17. The CASCADE investigators (1993) The CASCADE study. Am J Cardiol 72: 280–286

    Article  Google Scholar 

  18. Singh BN (1994) ICD not the ultimate gold standard for gauging therapy of VT/VF. Am J Cardiol 73: 121–125

    Article  Google Scholar 

  19. Chove W, Kim SG et al (1994) Comparison of defibrillator therapy and other therapeutic modalities of VT/VF associated with coronary artery disease. Am J Cardiol 73: 1075–1080

    Article  Google Scholar 

  20. Saksena S (1992) Survavival of ICD recipients. Circulation 4: 1616–1620

    Google Scholar 

  21. Kim SG (1993) ICD therapy. Am J Cardiol 71: 1213–1216

    Article  CAS  Google Scholar 

  22. Sweeney MO, Ruskin JN (1994) Mortality benefits and the ICD. Circulation 89: 1851–1857

    PubMed  CAS  Google Scholar 

  23. Zipes DP (1994) ICD: lifesaver or a device looking for a disease? Circulation 89: 2933–2937

    Google Scholar 

  24. Mower MM (1994) Letter to editor. PACE 17: 260–261

    Article  Google Scholar 

  25. Singer J (1994) Letter to editor. PACE 17: 261–263

    Google Scholar 

  26. Fogoros RN (1994) An AVID dissent. PACE 17: 1707–1710

    Article  PubMed  CAS  Google Scholar 

  27. Epstein AE (1994) Reply to Editor. PACE 17: 262–265

    Article  Google Scholar 

  28. Connolly S (1994) An AVID dissent commentary. PACE 17: 1712–1715

    Article  PubMed  CAS  Google Scholar 

  29. Siebels J, Cappato R et al (1993) ICD versus drug in cardiac arrest survivors. PACE 72: 103–106

    Google Scholar 

  30. Connolly S, Gent M et al (1993) Canadian ICD study. Am J Cardiol 72: 103–106

    Article  Google Scholar 

  31. The AVID investigators (1995) AVID: rationale, design and methods. Am J Cardiol 75: 470–474

    Article  Google Scholar 

  32. Weyer EF, Hauer RN et al (1995) Randomized study of ICD as first choice therapy versus conventional strategy in postinfarct sudden cardiac death survivors. Circulation 91: 2195–2203

    Google Scholar 

  33. Zipes DN (1995) Are ICD better than conventional antiarrhythmic drug for survivors of cardiac arrest? Circulation 91: 2115–2117

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Istituto di Cardiologia, Università Cattolica del Sacro Cuore, Rome, Italy

    F. Bellocci, G. Pelargonio, M. G. Bendini, A. Intini, V. Affinito, O. Sacchetti, G. Bruni, A. S. Montenero & P. Zecchi

Authors
  1. F. Bellocci
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. G. Pelargonio
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. M. G. Bendini
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. A. Intini
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. V. Affinito
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. O. Sacchetti
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. G. Bruni
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. A. S. Montenero
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. P. Zecchi
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Divisione di Cardiologia, Ospedale Umberto I, Via Circonvallazione 50, I-30174, Venezia Mestre, Italy

    Antonio Raviele MD

Rights and permissions

Reprints and permissions

Copyright information

© 1996 Springer-Verlag Italia, Milano

About this paper

Cite this paper

Bellocci, F. et al. (1996). Implantable Cardioverter Defibrillator: A Therapy for Everyone or for Selected Patients?. In: Raviele, A. (eds) Cardiac Arrhythmias 1995. Springer, Milano. https://doi.org/10.1007/978-88-470-2223-2_15

Download citation

  • DOI: https://doi.org/10.1007/978-88-470-2223-2_15

  • Publisher Name: Springer, Milano

  • Print ISBN: 978-3-540-75012-3

  • Online ISBN: 978-88-470-2223-2

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation